Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial

Lancet

Volumn 357, Issue 9268, 2001, Pages 1583-1585

  Böttiger, Bernd W ^a   Bode, Christoph ^a,b   Kern, Sabine ^a   Gries, André ^a   Gust, René ^a   Glätzer, Rolf ^a   Bauer, Harald ^a   Motsch, Johann ^a   Martin, Eike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN;

ADULT; ARTICLE; BLEEDING; CIRCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART RHYTHM; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL; TREATMENT OUTCOME;

EID: 0041451831     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04726-7     Document Type: Article

References (31)

1. Emergency Cardiac Care Committee and Subcommittees AHA. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 1992; 268: 2171-298.
2. Kudenchuk P.J., Cobb L.A., Copass M.K., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 341:1999;871-878.
3. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med. 229:1991;331-335.
4. Spaulding C.M., Joly L.M., Rosenberg A., et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 336:1997;1629-1633.
5. Bode C., Nordt T.K., Runge M.S. Thrombolytic therapy in acute myocardial infarction - selected recent developments. Ann Hematol. 69:1994;S35-40.
6. Goldhaber S.Z., Kessler C.M., Heit J.A., et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol. 20:1992;24-30.
7. Böttiger B.W. Thrombolysis during cardiopulmonary resuscitation. Fibrinolysis. 11:(suppl 2):1997;93-100.
8. Böttiger B.W., Böhrer H., Bach A., Motsch J., Martin E. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation. 28:1994;45-54.
9. Böttiger B.W., Reim S.M., Diezel G., Böhrer H., Martin E. High-dose bolus injection of urokinase; use during cardiopulmonary resuscitation for massive pulmonary embolism. Chest. 106:1994;1281-1283.
10. Langdon R.W., Swicegood W.R., Schwartz D.A. Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator. Ann Emerg Med. 18:1989;678-680.
11. Tiffany P.A., Schultz M., Steuven H. Bolus thrombolytic infusions during CPR for patients with refractory arrest rhythms: outcome of a case series. Ann Emerg Med. 31:1998;124-126.
12. Newman D.H., Greenwald I., Calleway C.W. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med. 35:2000;472-480.
13. Böttiger B.W., Motsch J., Böhrer H., et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation. 92:1995;2572-2578.
14. Fischer M., Böttiger B.W., Popov-Cenic S., Hossmann K.A. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med. 22:1996;1214-1223.
15. Gando S., Kameue T., Nanzaki S., Nakanishi Y. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost. 77:1997;278-282.
16. Fischer M., Hossmann K.A. No-reflow after cardiac arrest. Intensive Care Med. 21:1995;132-141.
17. Lin S.R., O'Connor M.J., Fischer H.W., King A. The effect of combined Dextran and streptokinase on cerebral function and blood flow after cardiac arrest: an experimental study on the dog. Invest Radiol. 13:1978;490-498.
18. Kim Y.H., Park J.H., Hong S.H., Koh J.Y. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science. 284:1999;647-650.
19. Cummins R.O., Chamberlain D.A., Abramson N.S., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein style. Circulation. 84:1991;960-975.
20. European Resuscitation Council. Guidelines for basic and advanced life support. Resuscitation 1992; 24: 103-21.
21. Fischer M., Fischer N.J., Schüttler J. One-year survival after out-of-hospital cardiac arrest in Bonn city: outcome report according to the 'Utstein style'. Resuscitation. 33:1997;233-243.
22. Böttiger B.W., Grabner C., Bauer H., et al. Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban/suburban area. Heart. 82:1999;674-679.
23. Scholz K.H., Tebbe U., Herrmann C., et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol. 69:1992;724-728.
24. Schiele R., Rustige J., Burcyk U., et al. Thrombolysis after resustication in acute myocardial infarction. J Am Coll Cardiol. 27:((suppl a)):1996;279A.
25. Darius H., Yanagisawa A., Brezinski M.E., Hock C.E., Lefer A.M. Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats. J Am Coll Cardiol. 8:1986;125-131.
26. Safar P., Xiao F., Radobsky A., et al. Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion. Stroke. 27:1996;105-113.
27. Hartveit F., Halleraker B. Intravascular changes in kidneys and lungs after external cardiac massage: a preliminary report. J Pathol. 102:1970;54-58.
28. Hekmatpanah J. Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology. 23:1973;174-180.
29. Crowell J.W., Sharpe G.P., Lambright R.L., Read W.L. The mechanism of death after resuscitation following acute circulatory failure. Surgery. 38:1955;696-702.
30. Crowell J.W., Smith E.E. Effect of fibrinolytic activation on survival and cerebral damage following periods of circulatory arrest. Am J Physiol. 186:1956;283-285.
31. Gaszynski W. The use of protease inhibitor (Trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system. Anaesth Resus Inten Therap. 3:1975;125-134.